Congenital Hypopigmentary Disorders with Multiorgan Impairment: A Case Report and an Overview on Gray Hair Syndromes.
Abnormalities, Multiple
/ diagnosis
Adult
Chediak-Higashi Syndrome
/ diagnosis
Child, Preschool
Craniofacial Abnormalities
/ diagnosis
Diagnosis, Differential
Female
Hair
/ abnormalities
Hearing Loss, Sensorineural
/ diagnosis
Humans
Hypertrichosis
/ chemically induced
Iris
/ abnormalities
Male
Mutation
Neurocutaneous Syndromes
/ diagnosis
Piebaldism
/ diagnosis
Pigmentation Disorders
/ diagnosis
Quality of Life
Rare Diseases
/ diagnosis
Skin Abnormalities
rab27 GTP-Binding Proteins
/ genetics
congenital hypopigmentary disorders
genetic skin disorders
genodermatoses
gray hair syndromes
griscelli syndrome
pigmentation disorders
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
25 Mar 2019
25 Mar 2019
Historique:
received:
25
02
2019
revised:
11
03
2019
accepted:
22
03
2019
entrez:
3
4
2019
pubmed:
3
4
2019
medline:
2
10
2019
Statut:
epublish
Résumé
The term congenital hypopigmentary disorders refers to a wide group of heterogeneous hereditary diseases, clinically characterized by inborn pigmentary defects of the iris, hair, and/or skin. They include Gray Hair Syndromes (GHSs), a rare group of autosomal recessive genodermatosis hallmarked by inborn silvery gray hair. GHSs encompass Griscelli, Chediak⁻Higashi, Elejalde, and Cross syndromes, which are all characterized by a broad spectrum of severe multisystem disorders, including neurological, ocular, skeletal, and immune system impairment. In this manuscript, we describe in detail the clinical, trichoscopic, and genetic features of a rare case of Griscelli syndrome; moreover, we provide an overview of all the GHSs known to date. Our report highlights how an accurate clinical examination with noninvasive methods, like trichoscopy, may play a crucial rule in diagnosis of rare and potentially lethal genetic syndromes such as Griscelli syndrome, in which timely diagnosis and therapy may modify the clinical course, quality of life, and likelihood of survival.
Identifiants
pubmed: 30934652
pii: medicina55030078
doi: 10.3390/medicina55030078
pmc: PMC6473230
pii:
doi:
Substances chimiques
rab27 GTP-Binding Proteins
0
RAB27A protein, human
EC 3.6.1.-.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Immunol. 2004 Jul;24(4):397-410
pubmed: 15163896
Acta Derm Venereol. 2010;90(1):6-11
pubmed: 20107718
Dermatology. 2011;223(4):306-10
pubmed: 22327602
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Indian Dermatol Online J. 2016 Nov-Dec;7(6):506-508
pubmed: 27990386
Intractable Rare Dis Res. 2017 Feb;6(1):76-79
pubmed: 28357189
Genes Dev. 2017 Apr 15;31(8):744-756
pubmed: 28465357
Hum Mutat. 2017 Oct;38(10):1355-1359
pubmed: 28585352
Neurol India. 2017 Jul-Aug;65(4):869-870
pubmed: 28681765
Int J Trichology. 2017 Jan-Mar;9(1):38-41
pubmed: 28761265
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e227-e229
pubmed: 29224231